Cervical Cancer Awareness Month -
Main Points for Articles
If you are developing articles or promotional materials
regarding Cervical Cancer Awareness Month, you may want to consider
including the following ideas, whether you are writing for the general
public, patients, or health care professionals.
Health care professionals have unique opportunities
to share information with the clients they serve. January is a good
time to discuss the importance of cervical cancer screening with
patients.
If you wish to write an article for health care
professionals and are looking for statistics on incidence and mortality,
stage at diagnosis, risk factors, or screening and diagnosis, please
refer to the Cervical Cancer Fact Sheets at www.michigancancer.org/Resources/CancerFactSheets.cfm.
January is Cervical Cancer Awareness Month.
Regular Pap smear testing is the key to preventing
deaths from cervical cancer.
The Pap smear test is still the most commonly used
cervical cancer screening method and has been proven to be effective
in decreasing the number of cervical cancers.
The major purpose of Pap smear tests is to find
abnormal changes in cells before they become cancer.
If the Pap smear test results are abnormal, additional
procedures must be done to determine if the changes might be the
beginning of cervical cancer.
These pre-cancerous changes, and very early cervical
cancer, are 100 percent curable.
Cervical cancer can be prevented using the same precautions
used for other sexually transmitted diseases.
The Michigan Cancer Consortium (MCC) recommends women
receive cervical cancer screening, including a Pap smear and speculum
exam, starting at age 21 or three years after the onset of sexual activity.
Most women have one or more high risk factors and should be screened
annually. As long as their status is low-risk, women may be screened
every two years (per the discretion of their provider) after three consecutive
annual negative Pap smears.
For more information about becoming involved in the
Michigan Cancer Consortium’s effort to increase cervical cancer screening
rates among women in high-risk populations, with appropriate follow-up
of abnormal screening results, call us (toll-free) at 877-588-MCCI or
e-mail us at .
*Please Note: You will need Adobe Acrobat Reader to open, view and print this file once it has been downloaded. If you need a free copy of Adobe Acrobat Reader, please click here.